Related Experiment Video
Updated: Jun 23, 2026

A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
Published on: October 31, 2012
How will genetic approaches assist in the management of respiratory diseases?
1Division of Therapeutics & Molecular Medicine, D Floor, South Block, QMC Campus, Nottingham University Hospitals, Nottingham NG7 2UH, UK. Ian.Hall@nottingham.ac.uk
Abstract:
There are a number of ways in which understanding the genetic basis of either disease pathogenesis or treatment response might be of value in the management of respiratory diseases. Although some single gene defect respiratory diseases such as cystic fibrosis exist, the majority of common respiratory diseases are caused by the interaction of multiple genes and environmental factors. Newer approaches including the use of genome wide association studies will help define the underlying genetic factors. Understanding the genetic basis for disease will throw new light on the pathophysiology of disease, may help redefine disease subtypes, and may also contribute to therapeutic approaches. The aim of this review is to assess the current state of our knowledge of these areas of research.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Respiratory Syncytial Virus Disease
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
What is Genetic Engineering?

